Exosome Diagnostics isolates exosomes, cell-derived vesicles, which contain RNA, DNA and proteins, from serum, plasma, urine, cerebralspinal fluid and saliva. The company performs molecular analysis of exosomes for diagnotics, disease detection, treatment and monitoring. Exosome Diagnostics collaborates with pharmaceutical companies such as Amgen and Takeda in research and development, biomarker discovery, validation and development of diagnostics.
While Chief Scientific Officer Johan Skog was at Massachusetts General Hospital, he was the first to demonstrate the detection of molecular mutations in a tumor in RNA extracted from exosomes in Nature Cell Biology in 2008.
Exosome Diagnostics raises a $27,000,000 series B round from CD-Venture, Arcus Ventures, Qiagen, Tiger Management Corp., Monashee Capital Corp, NGN Capital and Forbion Capital Partners.
Exosome Diagnostics raises a $6,500,000 series B round.
Exosome Diagnostics raises a $20,000,000 series A round from Forbion Capital Partners.
Exosome Diagnostics was founded.
Founding Scientist, CSO
Mikkel Noerholm, PhD
VP Product Development
Thomas McLain, MBA, CPA
William J. Kelly, CPA
Documentaries, videos and podcasts
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.
- CompanyA company, abbreviated 'co.', is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.
- Cluster: BiotechnologyA cluster of topics related to biotechnology.